Crossmark

Fertility treatment and oral contraceptive discontinuation for identification of pregnancy planning in routinely collected health data – an application to analgesic and antibiotic utilisation

Crossref DOI link: https://doi.org/10.1186/s12884-020-03435-4

Published Online: 2020-11-25

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hjorth, Sarah http://orcid.org/0000-0003-2841-5868
Wood, Mollie

Tauqeer, Fatima

Nordeng, Hedvig
Funding

Funding for this research was provided by:

European Research Council Starting Grant (639377)

National Heart, Lung, and Blood Institute (1T32HL098048 NHLBI)

PharmaTox Strategic Research Initiative
License Information

Text and Data Mining valid from 2020-11-25

Version of Record valid from 2020-11-25
More Information

Article History

Received: 16 July 2020

Accepted: 17 November 2020

First Online: 25 November 2020

Ethics approval and consent to participate

: The study was approved by the Regional Committee for Research Ethics in South Eastern Norway (approval number 2018/140/REK sør øst) and by the Data Protection Officer at the University of Oslo (approval number 58033). The Regional Committee for Research Ethics in South Eastern Norway has granted exemption from the obligation to seek consent from participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below